← Back to catalogue

Liquid Immunoassay Premium - Tri-Level (liq Ia Premium 1, 2 And 3)

FDA UDI

Class I (US FDA UDI)

by Randox Laboratories, Ltd.

Identity

Trade Name
LIQUID IMMUNOASSAY PREMIUM - TRI-LEVEL (LIQ IA PREMIUM 1, 2 AND 3) FDA UDI
Generic Name
Multiple-type clinical chemistry analyte profile IVD, control FDA UDI
Device Name
The Randox Liquid Immunoassay Premium - Tri-Level are liquid controls developed for use in the quality control of quantitative assays stated in this package insert. FDA UDI
Model / Reference
LIA3108 FDA UDI
Description
The Randox Liquid Immunoassay Premium - Tri-Level are liquid controls developed for use in the quality control of quantitative assays stated in this package insert. FDA UDI

Identifiers

Primary DI / UDI-DI
05055273207248 FDA UDI
FDA Product Code
JJY FDA UDI
GMDN Term
Multiple-type clinical chemistry analyte profile IVD, control FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
862.1660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple-type clinical chemistry analyte profile IVD, control

Liquid Immunoassay Premium - Tri-Level (liq Ia Premium 1, 2 And 3) by Randox Laboratories, Ltd. — Class I — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Multiple-type clinical chemistry analyte profile IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 1e649f1d-29a3-48de-8f45-993edcd7ea04 35 fields · synced May 31, 2026